In addition, changes in the lung due to inflammation, oxidative stress and pulmonary fibrosis mechanisms were evaluated.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Diabetes mellitus associated with oxidative stress and inflammation can affect many organs.
📊
Key Findings & Data:While the effects of diabetes on many organs are well known and documented, its mechanisms of action on the lung are known far less.
💡
Conclusion & Impact:In addition, changes in the lung due to inflammation, oxidative stress and pulmonary fibrosis mechanisms were evaluated.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:: Lung · Diabetes mellitus · fibrosis
Abstract
Diabetes mellitus associated with oxidative stress and inflammation can affect many organs. While the effects of diabetes on many organs are well known and documented, its mechanisms of action on the lung are known far less. Hyperglycemia can lead to lung damage by increasing oxidative stresses and inflammation. Diabetes may be a trigger for pulmonary fibrosis, as studies suggest that there may be an important link between pulmonary fibrosis and diabetes. In this review, the histopathological changes caused by diabetes in the lung tissue were summarized. In addition, changes in the lung due to inflammation, oxidative stress and pulmonary fibrosis mechanisms were evaluated.
YILDIRIM, A. B., KARABULUT, D., KAYMAK, E., KULOĞLU, N., AKIN, A., CEYLAN, T., ÖZTÜRK, E. (2023). Histopathological Changes In Lung Tissue Caused By Diabetes: A Review. Journal of Basic and Clinical Health Sciences, Cilt: 7 - Sayı: 1, 529–536. https://ajindex.com/articles/879871
Goldman MD. Lung dysfunction in diabetes. Diabetes care. 2003;26(6):1915-8
Pitocco D, Fuso L, Conte EG, Zaccardi F, Condoluci C, Scavone G, et al. The diabetic lung-a new target organ? Rev Diabet Stud 2012;9(1):23
Erdoğan BB, Uzaslan E. Diabetes and lung. Journal of Uludag University Faculty of Medicine 2005. 31;(1):71-74
Ramachandran A, Snehalatha C, Nanditha A. Classification and diagnosis of diabetes. In Holt RICockram CSFlyvbjerg A, Goldstein BJ, editors. Textbook of diabetes. 5th ed. Oxford, UK: Wiley-Blackwell; 2017. p. 23–8
Zhang RH, Cai YH, Shu LP, Yang J, Qi L, Han M, et al. Bidirectional relationship between diabetes and pulmonary function: a systematic review and meta-analysis. Diabetes Metab. 2020:101186
Nathan DM. Diabetes: advances in diagnosis and treatment. Jama 2015;314(10):1052-62
Khateeb J, Fuchs E, Khamaisi M. Diabetes and lung disease: a neglected relationship Rev Diabet Stud 2019;15:1
Kinney GL, Black-Shinn JL, Wan ES, Make B, Regan E, Lutz S, et al. Pulmonary function reduction in diabetes with and without chronic obstructive pulmonary disease. Diabetes care 2014;37(2):389-95
Matsubara T, Hara F. The pulmonary function and histopathological studies of the lung in diabetes mellitus. Nihon Ika Daigaku Zasshi 1991;58(5):528-36
Ehrlich SF, Quesenberry CP, Van Den Eeden SK, Shan J, Ferrara A. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes care 2010;33(1):55-60
Chen CM, Juan SH, Pai MH, Chou HC. Hyperglycemia induces epithelial–mesenchymal transition in the lungs of experimental diabetes mellitus. Acta histochem 2018;120(6):525-33
Honiden S, Gong MN. Diabetes, insulin, and development of acute lung injury. Crit. Care Med 2009;37(8):2455
Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med 2003;114(9):758-62
Di Naso FC, Forgiarini Júnior LA, Forgiarini LF, Porawski M, Dias AS, Marroni NAP. Aminoguanidine reduces oxidative stress and structural lung changes in experimental diabetes mellitus. J Bras Pneumol 2010; 36, 485-489
Klein O, Krishnan J, Glick S, Smith L. Systematic review of the association between lung function and Type 2 diabetes mellitus. Diabetic Med 2010;27(9):977-87
Hsia CC, Raskin P. Lung function changes related to diab